Glucose monitoring system recommended by NICE
The National Institute for Health and Care Excellence (NICE) has recommended the MiniMed Paradigm Veo system as an option for managing blood glucose levels in people with type 1 diabetes only if: they have episodes of disabling hypoglycaemia despite optimal management with continuous subcutaneous insulin infusion and the company arranges to collect, analyse and publish data on the use of the MiniMed Paradigm Veo system. Further information about this decision can be found on the NICE website.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200740
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com